2026-10-14T05:48:45Z https://data.mendeley.com/oai

oai:data.mendeley.com/8g4y7gkjrf.2 2023-08-09T06:00:42Z

Gargiulo, Luigi Supplementary files "Long-term effectiveness and safety of risankizumab for the treatment of plaque psoriasis in a real-life Italian multicenter cohort - IL PSO (ITALIAN LANDSCAPE PSORIASIS)" Mendeley Data Supplementary Figure 1. Mean PASI trend during the study. PASI: Psoriasis Area and Severity Index. Supplementary Figure 2. Effectiveness of risankizumab according to previous exposure to biological therapies. PASI: Psoriasis Area and Severity Index. * p-value < 0.05; ** p-value ≤ 0.01; *** p-value ≤ 0.001 Supplementary Figure 3. Kaplan-Meier curve of all-cause treatment discontinuation in all patients treated with risankizumab up to 36 months. Supplementary Table 1. Mean PASI at each time-point according to all analyzed variables. PASI: Psoriasis Area and Severity Index. mPASI: mean PASI; PsA: Psoriatic Arthritis; CMD: Cardio-Metabolic Disease; BMI: Body Mass Index. Supplementary Table 2. Effectiveness of risankizumab according to the concomitant presence of PsA. PsA: Psoriatic Arthritis Supplementary Table 3. Effectiveness of risankizumab according to the presence of cardio-metabolic comorbidities and involvement of difficult-to-treat areas. PASI: Psoriasis Area and Severity Index; OR: Odds Ratio; CI: Confidence Interval; CMD: Cardio-Metabolic Disease; NA: Not Applicable (multivariate analysis was not performed for these variables, as the p-value at univariate analysis was ≥ 0.2); NS: Not Significant Supplementary Table 4. Effectiveness of risankizumab according to BMI classes. BMI: Body Mass Index; OR: Odds Ratio; CI: Confidence Interval; NA: Not Applicable (multivariate analysis was not performed for these variables, as the p-value at univariate analysis was ≥ 0.2); NS: Not Significant. ^ Obese versus normal-weight patients; * Obese versus overweight patients; ° Normal-weight versus overweight patients. Dermatology Dataset doi:10.17632/8g4y7gkjrf.2 oai:data.mendeley.com/8g4y7gkjrf.2 Creative Commons Attribution 4.0 International http://creativecommons.org/licenses/by/4.0 https://data.mendeley.com/datasets/8g4y7gkjrf 2023-08-09T06:00:42Z 2023-11-08T23:59:59Z